The Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Exendin-4 Reduces Cocaine Self-Administration in Mice

Glucagon-like peptide 1 (GLP-1) analogues are used for the treatment of type 2 diabetes. The ability of the GLP-1 system to decrease food intake in rodents has been well described and parallels results from clinical trials. GLP-1 receptors are expressed in the brain, including within the ventral teg...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Physiol Behav
Autors principals: Sørensen, Gunnar, Reddy, India A., Weikop, Pia, Graham, Devon L., Stanwood, Gregg D., Wortwein, Gitta, Galli, Aurelio, Fink-Jensen, Anders
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4668599/
https://ncbi.nlm.nih.gov/pubmed/26072178
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.physbeh.2015.06.013
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars